Skip to main contentAI and Advanced
/
BI · NSEBSE SENSEX74,384.96+0.07%BSE |
NIFTY 5023,273.45+0.24%NSE |
NIFTY BANK56,176.65-0.21%NSE |
NIFTY IT29,003.9-0.29%NSE |
NIFTY AUTO27,169.55+1.03%NSE |
NIFTY FMCG45,634.45+0.17%NSE |
NIFTY PHARMA26,432.5+1.09%NSE |
NIFTY 50022,634.45+0.45%NSE |
BI
NSE · Equity shares · Containers & Packaging4.99 · 5.47%
Bilcare BI
NSE:INR 96.24
BSE:INR 60.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for BI
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 91.25
Day rangeINR 87.08 — INR 96.24
52-week rangeINR 51.62 — INR 111.51
Volume1.00 L
Market cap142.51
P/E83.15
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)733.54
Net Income (INR Cr)1.72
Rev Growth (5 Year %)3.33
P/E Ratio83.15
Book Value80.3
EPS1.78
Price/BV1.20Computed
Research path: Interpret Bilcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
BIBilcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 842.83 | 924.1 | 977.21 |
| Other Liabilities Total | 13.13 | 17.16 | 3.63 |
| Long Term Debt | 449.72 | 451.47 | 544.47 |
| Common Stock Total | 23.55 | 23.55 | 23.55 |
| Other Current Assets Total | 77.16 | 77.1 | 88.13 |
| Total Assets | 842.83 | 924.1 | 977.21 |
| Current Portof LT Debt/Capital Leases | 160.42 | 218.74 | 210.64 |
| Cash | 5.51 | 15.01 | 36.42 |
| Total Equity | 196.73 | 214.22 | 210.94 |
| Long Term Investments | 25.57 | 97.75 | 95.32 |
| Retained Earnings(Accumulated Deficit) | 173.18 | 190.67 | 187.39 |
| Total Common Shares Outstanding | 2.35 | 2.35 | 2.35 |
| Tangible Book Valueper Share Common Eq | 80.3 | 86.21 | 84.3 |
| Total Liabilities | 646.1 | 709.88 | 766.27 |
| Total Debt | 620.44 | 689.1 | 756.05 |
| Short Term Investments | 46.98 | 14.42 | 16.15 |
| Cashand Short Term Investments | 52.49 | 29.43 | 52.57 |
| Total Receivables Net | 108.83 | 119.36 | 164.24 |
| Deferred Income Tax | 3.38 | 7.3 | 22.5 |
| Accounts Receivable-Trade Net | 108.04 | 118.89 | 149.82 |
| Property/Plant/Equipment Total-Net | 433.74 | 448.98 | 436.54 |
| Minority Interest | -122.59 | -124.59 | -155.32 |
| Total Current Liabilities | 292.16 | 339.65 | 350.05 |
| Total Inventory | 114.84 | 117.12 | 106.25 |
| Accounts Payable | 93.75 | 83.68 | 96.58 |
| Other Currentliabilities Total | 37.99 | 37.23 | 42.83 |
| Total Long Term Debt | 460.02 | 470.36 | 545.41 |
| Intangibles Net | 7.66 | 11.23 | 12.46 |
| Other Long Term Assets Total | 14.89 | 13.64 | 13.07 |
| Note Receivable-Long Term | 7.65 | 9.49 | 8.63 |
| Total Current Assets | 353.32 | 343.01 | 411.19 |
| Capital Lease Obligations | 10.3 | 18.89 | 0.94 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %-1.74
Margins
Operating Margin 12m0.96
Operating Margin 5y Avg8
Net Profit Margin 12m-4.24
Net Profit Margin 5y-1.42
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio0.19
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk44.9
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| EPL | INR 234.05 | 7,485.4 | 18.66 | — |
| AGI Greenpac | INR 674.55 | 4,361.61 | 12.66 | — |
| Xpro India | INR 1,357.3 | 3,182.45 | 166.68 | — |
| Uflex | INR 505 | 3,660.26 | 9.47 | — |
| TCPL Packaging | INR 3,339.2 | 2,987.83 | 26.65 | — |
Shareholding
Ownership
- Promoter
- 30.01%
- FII
- 0.04%
- Other
- 69.95%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Bilcare Ltd is Rated Sell by MarketsMOJO - MarketsMojoMarket news · 11 Jul 2026, 1:26 am
Bilcare Ltd is Rated Sell by MarketsMOJO MarketsMojo
Enterprise value to EBIT forward of Bilcare Ltd – NSE:BI - TradingViewMarket news · 30 Jun 2026, 5:09 am
Enterprise value to EBIT forward of Bilcare Ltd – NSE:BI TradingView
Enterprise value to EBITDA forward of Bilcare Ltd – BSE:BI - TradingViewMarket news · 29 Jun 2026, 10:14 pm
Enterprise value to EBITDA forward of Bilcare Ltd – BSE:BI TradingView
Price to book forward of Bilcare Ltd – BSE:BI - TradingViewMarket news · 29 Jun 2026, 10:03 am
Price to book forward of Bilcare Ltd – BSE:BI TradingView
Compare Bilcare with - EquitymasterMarket news · 26 Jun 2026, 4:58 am
Compare Bilcare with Equitymaster
Bilcare Ltd directed to deposit outstanding FD amounts to IEPF - scanx.tradeMarket news · 12 Jun 2026, 12:30 pm
Bilcare Ltd directed to deposit outstanding FD amounts to IEPF scanx.trade
Corporate actions
Events
- annual General MeetingPOM
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General Meeting(Revised)
- board MeetingsQuarterly Results
- board MeetingsAudited Results
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Bilcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Bilcare Limited is an India-based company. The Company is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, and Research and Development (R&D) services. It has a single operating segment, namely Pharma Packaging Research Solutions. The Company offers a range of Pharma Packaging solutions, namely Blister Films, Blister Foils, Lidding Foils, Child-resistant (CR) Foils, and Laminations. Its R&D services include Formulation stability studies, Blister / Foil design & development, Pharma brand innovation, Analytical research & market study, and Packaging trials & audit. The Company has five subsidiaries, namely Bilcare GCS Limited, Bilcare Inc., Bilcare GCS Inc., Bilcare GCS Ireland Limited, Bilcare Pharma Solutions Limited, and Caprihans India Limited. Its annual manufacturing capacity is approximately 50000 tons. The Company has manufacturing facilities in Nashik, Pune, and Thane.
Company facts
- Industry
- Containers & Packaging
- Sector
- Containers & Packaging
- NSE Code
- BI
- BSE Code
- 526853
Questions
Stock FAQ
What is the symbol and ISIN of Bilcare?
Bilcare has the symbol BI and ISIN - INE986A01012.
What is the current price of Bilcare?
Bilcare is currently trading at INR 96.24.
What are the year high and year low of Bilcare?
Bilcare has a year high of INR 111.51 and a year low of INR 51.62.
What is the market capitalization of Bilcare?
Bilcare has a market capitalization of INR 142.51 crore.
What is the P/E ratio of Bilcare?
Bilcare has a P/E ratio of 83.15.
What is the dividend yield of Bilcare?
Bilcare has a dividend yield of 0.00%.
How is the financial performance of Bilcare based on revenue, net income, and EPS?
Bilcare has revenue of INR 733.54 crore, net income of INR 1.72 crore, and EPS of INR 0.30.
What is the book value of Bilcare?
Bilcare has a book value of INR 80.30.
What is the debt-to-equity ratio of Bilcare?
Bilcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Bilcare?
Bilcare has a price-to-book ratio of 1.20 and a price-to-sales ratio of 0.19.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.